Intangible Assets

SRTS appears to rely on a narrow set of service relationships rather than protected intellectual property, so peers with similar clinical or operational capabilities can replicate the offering more easily.

The absence of disclosed long-run margin or ROIC strength versus peers suggests any brand or reputation advantage is not translating into durable pricing power.

Compared with larger healthcare services peers that benefit from recognized brands, broader referral channels, or proprietary data, SRTS looks less protected by intangible assets.

Switching Costs

The very negative TTM ROIC and ROCE indicate customers are not locked into a high-return installed base, which is consistent with limited switching friction.

A cash conversion cycle above 500 days points to working-capital intensity rather than customer lock-in, so retention appears driven more by service continuity than by hard switching barriers.

Relative to peers with embedded workflows, payer integrations, or proprietary platforms, SRTS appears easier to replace and therefore has weaker switching costs.

Network Effects

SRTS does not appear to operate a platform where each additional customer materially improves the product for other customers, so there is little evidence of self-reinforcing demand.

Unlike peer businesses with data-network or marketplace effects, SRTS’s value proposition is not visibly amplified by scale-driven user interactions.

Without a clear ecosystem that compounds with usage, network effects are not a meaningful source of moat durability versus peers.

Cost Advantage

Negative ROIC and ROCE imply SRTS is not converting capital into returns efficiently, which argues against a structural cost advantage versus peers.

The high cash conversion cycle suggests operating efficiency is not strong enough to create a persistent unit-cost edge.

Compared with larger peers that can spread fixed costs across broader volumes, SRTS does not show evidence of a durable cost advantage.

Efficient Scale

SRTS does not appear to serve a market structure where one or a few incumbents can profitably dominate capacity and deter entry, so efficient-scale protection looks limited.

The weak capital returns indicate scale is not currently translating into a defensible operating advantage over peers.

Relative to larger competitors with broader geographic reach or denser referral networks, SRTS appears too small to enjoy meaningful efficient-scale insulation.

Overall Score

SRTS shows little evidence of a durable economic moat versus peers because the available metrics point to weak capital efficiency, limited switching friction, and no visible network or scale-based protection; any competitive advantage appears modest and replicable rather than structurally durable.